Tom Giovanetti is president of the Institute for Policy Innovation (IPI), a conservative, free-market public policy research organization based in Dallas, Texas.
In addition to his administrative duties, Tom writes for IPI and for leading publications on a variety of policy topics including taxes and economic growth, self-government and the Founders' design, civil liberties and constitutional protections, judicial supremacy, intellectual property, Social Security personal accounts, technology and Internet policy, and out-of-control government spending. In addition to being regularly published in major outlets including the Wall Street Journal, Washington Times, FoxNews.com and The Dallas Morning News, Tom has a regular column in the Fort Worth Star-Telegram. Tom frequently appears in the media and is a fill-in host for the Mark Davis Show in the Dallas-Fort Worth market.
Tom's passion is encouraging conservative voters and organizations to remain skeptical of Big Government, maintain faith in markets, and defend individual liberty as the best means of achieving human flourishing. His most recent work has focused on free-market solutions to the student debt issue, preserving freedom of speech online, and persuading state legislatures to override local and municipal policies that restrict economic liberty.
Mr. Giovanetti has represented IPI at many national and international organizations, including the World Intellectual Property Organization (WIPO), the Internet Governance Forum (IGF) the World Health Organization (WHO) and represented IPI during trade agreement negotiations on the Trans-Pacific Partnership (TPP).
Mr. Giovanetti is a popular speaker and writer, and also testifies before state and federal legislative committees on a variety of topics.
Follow Tom on Twitter at @tgiovanetti
Luring Medical Manufacturing Home with the BEAT CHINA Act
The BEAT CHINA Act is a “two-fer”—a major move toward a more pro-growth tax code and a carrot rather than a stick approach toward bringing critical manufacturing home.
Coalition Letter Regarding Intellectual Property of COVID-19 Research
Coalition letter in opposition to lawmakers actions that would deny patents, exclusivity, and property rights to biomedical innovators working on vaccines, diagnostics, therapies, and cures for COVID-19.
The Least Eventful Tax Day in History
Could the Covid-19 virus be the crisis that forces the federal government to begin setting its house in order?
Coalition Letter Regarding the Proposed "Buy American" Mandate
If implemented, a Buy American mandate would disrupt existing supply chains, invite retaliatory actions from trading partners, and threaten timely access to medicines. In this current health crisis, such a mandate could even threaten our ability to adequately respond to the pandemic.
Coalition Letter Advocating Transparency and Oversight of Coronavirus Stimulus Spending
Bipartisan groups lay out principles for transparency and oversight of coronavirus stimulus spending.
A Better Solution to the Covid-19 Economic Crisis
This plan delivers the right amount of aid to the right people, and minimizes the eventual drain on taxpayer dollars.
Free-marketeer: Better Than a Stimulus Plan
Total Records: 728
